Advances in the management of hepatobiliary and pancreatic malignancies: highlights from the ESMO Annual Meeting 2023 by the EORTC GI Tract Cancer Group
C. Fulgenzi,
I. Garajová,
M. Moehler,
M.P. Lutz,
E. Smyth,
L. Rimassa,
C. Neuzillet,
A. Lamarca
Affiliations
C. Fulgenzi
European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK
I. Garajová
European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Medical Oncology Unit, University Hospital of Parma, Parma, Italy
M. Moehler
European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Department of Internal Medicine, Johannes-Gutenberg University, Mainz
M.P. Lutz
European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Caritasklinikum, Saarbrucken, Germany
E. Smyth
European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
L. Rimassa
European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
C. Neuzillet
European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Institut Curie, Versailles Saint-Quentin University - Paris Saclay University, Saint-Cloud, France
A. Lamarca
European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Department of Medical Oncology, Oncohealth Institute, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, Fundación Jimenez Diaz University Hospital, Madrid, Spain
